Physician profile
Tom Ju
NPI 1508201393
$15,571.05
in general payments reported to CMS, 2019-2025
38 companies · $1,795 in 2025
The $1,795 reported for 2025 was more than what 76% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $1,065 · 2021: $1,935 · 2022: $2,235 · 2023: $5,855 · 2024: $1,504 · 2025: $1,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,127 · Travel and Lodging: $3,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,126.94 |
| Travel and Lodging | $3,027.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,988.04 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Vanta Adaptivestim |
| Nevro Corp. | $1,481.02 | 2020-2024 | Senza |
| Globus Medical, INC. | $1,166.73 | 2025 | Senza |
| Nalu Medical, INC. | $1,107.92 | 2021-2025 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $751.22 | 2019-2025 | |
| Abbott Laboratories | $746.16 | 2019-2023 | Proclaim |
| Collegium Pharmaceutical, INC. | $710.08 | 2019-2025 | Belbuca |
| Boston Scientific Corporation | $690.38 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Bioventus LLC | $560.42 | 2022-2023 | Stimrouter Implantable Kit |
| Curonix LLC | $510.34 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biodelivery Sciences International, INC. | $328.22 | 2020-2021 | |
| Stimwave Technologies Incorporated | $193.35 | 2019-2022 | |
| Redhill Biopharma INC. | $178.42 | 2020-2021 | |
| Fidia Pharma USA INC. | $170.08 | 2019-2025 | Hymovis, Triluron |
| Amgen INC. | $131.35 | 2019-2025 | Evenity, Prolia |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Ju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.